Neha Manpuria
Stock Analyst at Bank of America Securities
(2.57)
# 2,943
Out of 5,058 analysts
21
Total ratings
60%
Success rate
4.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Neha Manpuria
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RDY Dr. Reddy's Laboratories | Reiterated: Buy | n/a | $12.75 | - | 7 | Oct 1, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Reiterated: Buy | ₹1,620 → ₹1,600 | ₹1,226 | +30.50% | 2 | Dec 15, 2025 | |
| NSE: ALKEM Alkem Laboratories Limited | Upgraded: Hold | ₹5,530 | ₹5,209 | n/a | 1 | Aug 13, 2025 | |
| NSE: LUPIN Lupin Limited | Upgraded: Hold | ₹1,930 → ₹1,970 | ₹1,979 | n/a | 2 | Aug 8, 2025 | |
| NSE: CIPLA Cipla Limited | Reiterated: Sell | ₹1,420 → ₹1,500 | ₹1,328 | n/a | 2 | Jul 27, 2025 | |
| NSE: AUROPHARMA Aurobindo Pharma Limited | Reiterated: Buy | ₹1,350 | ₹1,673 | n/a | 1 | May 27, 2025 | |
| NSE: MANKIND Mankind Pharma Limited | Reiterated: Sell | ₹2,150 | ₹2,349 | n/a | 1 | May 21, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Reiterated: Hold | ₹1,170 | ₹868.40 | n/a | 1 | May 21, 2025 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Reiterated: Buy | ₹7,150 | ₹9,047 | n/a | 1 | May 19, 2025 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹8,150 | ₹7,960 | n/a | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,020 | ₹3,055 | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,940 | ₹1,759 | n/a | 1 | Jan 31, 2025 |
Dr. Reddy's Laboratories
Oct 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.75
Upside: -
Dr. Reddy's Laboratories Limited
Dec 15, 2025
Reiterated: Buy
Price Target: ₹1,620 → ₹1,600
Current: ₹1,226
Upside: +30.50%
Alkem Laboratories Limited
Aug 13, 2025
Upgraded: Hold
Price Target: ₹5,530
Current: ₹5,209
Upside: n/a
Lupin Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹1,930 → ₹1,970
Current: ₹1,979
Upside: n/a
Cipla Limited
Jul 27, 2025
Reiterated: Sell
Price Target: ₹1,420 → ₹1,500
Current: ₹1,328
Upside: n/a
Aurobindo Pharma Limited
May 27, 2025
Reiterated: Buy
Price Target: ₹1,350
Current: ₹1,673
Upside: n/a
Mankind Pharma Limited
May 21, 2025
Reiterated: Sell
Price Target: ₹2,150
Current: ₹2,349
Upside: n/a
Max Healthcare Institute Limited
May 21, 2025
Reiterated: Hold
Price Target: ₹1,170
Current: ₹868.40
Upside: n/a
Divi's Laboratories Limited
May 19, 2025
Reiterated: Buy
Price Target: ₹7,150
Current: ₹9,047
Upside: n/a
Apollo Hospitals Enterprise Limited
Feb 11, 2025
Reiterated: Buy
Price Target: ₹8,150
Current: ₹7,960
Upside: n/a
Feb 4, 2025
Reiterated: Buy
Price Target: ₹2,020
Current: ₹3,055
Upside: n/a
Jan 31, 2025
Reiterated: Hold
Price Target: ₹1,940
Current: ₹1,759
Upside: n/a